431 related articles for article (PubMed ID: 23006246)
1. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
[TBL] [Abstract][Full Text] [Related]
2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
[TBL] [Abstract][Full Text] [Related]
5. Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.
Du J; Sun H; Huang D; Jiang H; Zhong N; Xu D; Zhao Y; Lin S; Wang W; Du Z; Zhao M; Hser YI
Drug Alcohol Depend; 2014 Oct; 143():44-50. PubMed ID: 25081602
[TBL] [Abstract][Full Text] [Related]
6. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
Grolleau A; Cougnard A; Bégaud B; Verdoux H
Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
[TBL] [Abstract][Full Text] [Related]
7. Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China.
Zhang Y; Xu Z; Zhang S; Desrosiers A; Schottenfeld RS; Chawarski MC
J Psychiatr Res; 2014 Jun; 53():99-102. PubMed ID: 24613031
[TBL] [Abstract][Full Text] [Related]
8. Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats.
Kuwayama K; Inoue H; Kanamori T; Tsujikawa K; Miyaguchi H; Iwata Y; Miyauchi S; Kamo N; Kishi T
Forensic Sci Int; 2007 Aug; 170(2-3):183-8. PubMed ID: 17614227
[TBL] [Abstract][Full Text] [Related]
9. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
Uosukainen H; Tacke U; Winstock AR
Int J Drug Policy; 2015 Jan; 26(1):78-83. PubMed ID: 25107829
[TBL] [Abstract][Full Text] [Related]
10. Dental health of Irish alcohol/drug abuse treatment centre residents.
O'Sullivan EM
Community Dent Health; 2012 Dec; 29(4):263-7. PubMed ID: 23488206
[TBL] [Abstract][Full Text] [Related]
11. [Current situation and clinical characteristics of sedative-related disorder patients in Japan: a comparison with methamphetamine-related disorder patients].
Matsumoto T; Ozaki S; Kobayashi O; Wada K
Seishin Shinkeigaku Zasshi; 2011; 113(12):1184-98. PubMed ID: 22352004
[TBL] [Abstract][Full Text] [Related]
12. Major depression: the relative contribution of gender, MDMA, and cannabis use.
Durdle H; Lundahl LH; Johanson CE; Tancer M
Depress Anxiety; 2008; 25(3):241-7. PubMed ID: 17345601
[TBL] [Abstract][Full Text] [Related]
13. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
Bolton JM; Robinson J; Sareen J
J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
Gum AM; King-Kallimanis B; Kohn R
Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of patients with designer-drug-related disorder in Japan: a comparison with patients with methamphetamine- and hypnotic/anxiolytic-related disorders.
Matsumoto T; Tachimori H; Tanibuchi Y; Takano A; Wada K
Psychiatry Clin Neurosci; 2014 May; 68(5):374-82. PubMed ID: 24405505
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric morbidity in ketamine users attending counselling and youth outreach services.
Tang WK; Morgan CJ; Lau GC; Liang HJ; Tang A; Ungvari GS
Subst Abus; 2015; 36(1):67-74. PubMed ID: 25023206
[TBL] [Abstract][Full Text] [Related]
17. Posttraumatic stress disorder, gender, and problem profiles in substance dependent patients.
Peirce JM; Kindbom KA; Waesche MC; Yuscavage AS; Brooner RK
Subst Use Misuse; 2008; 43(5):596-611. PubMed ID: 18393079
[TBL] [Abstract][Full Text] [Related]
18. [Current situation of substance abuse/dependence in psychiatric hospital settings].
Ozaki S
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Feb; 39(1):35-40. PubMed ID: 15058092
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of psychiatric disorders in the general population of Kashan, Iran.
Ahmadvand A; Sepehrmanesh Z; Ghoreishi FS; Afshinmajd S
Arch Iran Med; 2012 Apr; 15(4):205-9. PubMed ID: 22424036
[TBL] [Abstract][Full Text] [Related]
20. The synergistic effect of dual use of amphetamine-type stimulants and ketamine on drug-induced psychotic symptoms in Chinese synthetic drug users.
Liu XB; Zhang Y; Wang XY; Hao W
Oncotarget; 2017 Sep; 8(39):66569-66575. PubMed ID: 29029537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
